STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1067 by analyst upside · 2026-08-13
TLRY
Tilray Brands, Inc.
Healthcare · Market Cap $637M · P/E 0x
ANALYST PRICE TARGET
+67.6%
implied upside to consensus target
Current Price $4.68
Consensus Target $7.84
Bull Target $19.0
Bear Target $4.25
Analysts Covering 8
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
2
Hold
6
Sell
0
52-Week Low $3.67
52-Week High $23.2
YTD Return -51.9%
FUNDAMENTALS
Market Cap $637M
P/E Ratio (TTM) N/A
Forward P/E 10.4x
EPS (TTM) $-1.07
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $915M
Profit Margin -13.3%
52-WEEK RANGE
52-Week Low $3.67
52-Week High $23.2
Current Price $4.68
Bear Target $4.25
Bull Target $19.0
● Now $4.68 ● Target $7.84
TRADING DATA
Avg Volume 4.0M
YTD Return -51.9%
Analyst Count 8
Consensus Hold
Upside to Target +67.6%
Last Updated 2026-08-13

ANALYST SUMMARY

Tilray Brands, Inc. (TLRY) is currently trading at $4.68 with a Wall Street consensus price target of $7.84, implying potential upside of 67.6% over the next 12 months. 8 analysts currently cover TLRY, with a consensus rating of Hold - 25% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $19.0, while the most cautious has a target of $4.25.

TLRY operates in the Healthcare sector with a market capitalisation of $637M. The stock is down 51.9% year-to-date and is currently trading near the lower end of its 52-week range of $3.67 – $23.2.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for TLRY, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Roth Capital ↑ Upgrade
Neutral → Buy 2026-04-02 Building track record
TD Cowen - Reiterated
Buy → Buy 2026-03-30 Building track record
Roth Capital - Reiterated
Neutral → Neutral 2026-01-20 Building track record
Jefferies - Reiterated
Buy → Buy 2025-08-25 50% win rate (6 calls)
Zelman & Assoc reit
Neutral → Neutral 2025-07-29 Building track record
Piper Sandler - Reiterated
Neutral → Neutral 2025-04-09 14% win rate (7 calls)
Roth MKM - Reiterated
Neutral → Neutral 2024-10-11 25% win rate (12 calls)
Zuanic & Associates ● Initiated
Neutral 2024-06-27 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
19
out of 100
Coverage depth
17/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →